“Adding Moderna’s in-development cancer vaccine to a standard treatment for melanoma dramatically reduces cancer survivors’ risk of death or recurrence, according to newly shared trial data.”
From Freethink.
01 / 05
Moderna’s mRNA Cancer Vaccine Works Even Better than Thought
“In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85% – roughly 109 million – completed all three doses, according to new national immunization coverage data released today by the World Health Organization (WHO) and UNICEF.
Compared to 2023, around 171 000 more children received at least one vaccine, and one million more completed the full three-dose DTP series. While the gains are modest, they signal continued progress by countries working to protect children, even amid growing challenges.”
“England will be the first country in the world to start vaccinating people against the sexually transmitted infection gonorrhoea.
It will not be available for everyone. The focus will mainly be on gay and bisexual men with a history of multiple sexual partners or an STI.
The vaccine is 30-40% effective, but NHS England hopes it will reverse soaring numbers of infections.
There were more than 85,000 cases in 2023 – the highest since records began in 1918.”
From BBC.
“For farmers in Latin America, vampire bats live up to their dark reputation. Their bites weaken cows and open the way for infections. Worst of all, the rabies they sometimes carry can kill livestock and, occasionally, people as well. Now scientists have developed an innovative way to vaccinate the bats against the virus—by making use of their extraordinary fondness of mutual grooming.
In a study published as a biorXiv preprint on 12 June, researchers showed that after they applied an oral vaccine in the form of a thick gel to the fur of some members of a colony of common vampire bats (Desmodus rotundus), mutual licking helped spread the vaccine rapidly through the population.”
From Science.
“By 2023, Gavi had worked with over 40 countries to provide the HPV vaccine to 23.7 million girls. This massive immunisation effort is projected to avert over 605,000 future deaths from cervical cancer, a testament to the vaccine’s life-saving potential.
In 2023 alone, Gavi-supported countries vaccinated more than 14 million girls – more than the total number vaccinated in the previous decade combined. Thanks to an unprecedented scale-up of vaccine introductions, dedicated investment and expanded access since 2023, Gavi is on track to reach its ambitious goal of protecting 86 million girls with the HPV vaccine by 2025, a milestone that is expected to prevent more than 1.4 million future cervical cancer deaths.”
From Gavi.